Literature DB >> 30593613

Enhancer RNAs: a missing regulatory layer in gene transcription.

Renfang Mao1, Yuanyuan Wu2, Yue Ming3, Yuanpei Xu3, Shouyan Wang2, Xia Chen2, Xiaoying Wang3, Yihui Fan4,5.   

Abstract

Enhancers and super-enhancers exert indispensable roles in maintaining cell identity through spatiotemporally regulating gene transcription. Meanwhile, active enhancers and super-enhancers also produce transcripts termed enhancer RNAs (eRNAs) from their DNA elements. Although enhancers have been identified for more than 30 years, widespread transcription from enhancers are just discovered by genome-wide sequencing and considered as the key to understand longstanding questions in gene transcription. RNA-transcribed enhancers are marked by histone modifications such as H3K4m1/2 and H3K27Ac, and enriched with transcription regulatory factors such as LDTFs, P300, CBP, BRD4 and MED1. Those regulatory factors might constitute a Mega-Trans-like complex to potently activate enhancers. Compared to mRNAs, eRNAs are quite unstable and play roles at local. Functionally, it has been shown that eRNAs promote formation of enhancer-promoter loops. Several studies also demonstrated that eRNAs help the binding of RNA polymerase II (RNAPII) or transition of paused RNAPII by de-association of the negative elongation factor (NELF) complex. Nevertheless, these proposed mechanisms are not universally accepted and still under controversy. Here, we comprehensively summarize the reported findings and make perspectives for future exploration. We also believe that super-enhancer derived RNAs (seRNAs) might be informative to understand the nature of super-enhancers.

Entities:  

Keywords:  enhancer RNAs (eRNAs); enhancers; gene transcription; super-enhancer RNAs (seRNAs); super-enhancers

Mesh:

Substances:

Year:  2018        PMID: 30593613     DOI: 10.1007/s11427-017-9370-9

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  13 in total

Review 1.  Non-coding RNAs: the new central dogma of cancer biology.

Authors:  Phei Er Saw; Xiaoding Xu; Jianing Chen; Er-Wei Song
Journal:  Sci China Life Sci       Date:  2020-09-11       Impact factor: 6.038

Review 2.  Oncogenic seRNA functional activation: a novel mechanism of tumorigenesis.

Authors:  Yuan Tan; Yuejin Li; Faqing Tang
Journal:  Mol Cancer       Date:  2020-04-11       Impact factor: 27.401

3.  Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma.

Authors:  Huiming Jiang; Haibin Chen; Pei Wan; Shengda Song; Nanhui Chen
Journal:  Aging (Albany NY)       Date:  2020-11-25       Impact factor: 5.682

Review 4.  Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance.

Authors:  Guo-Hua Li; Qiang Qu; Ting-Ting Qi; Xin-Qi Teng; Hai-Hong Zhu; Jiao-Jiao Wang; Qiong Lu; Jian Qu
Journal:  J Exp Clin Cancer Res       Date:  2021-05-19

5.  Transcriptional Landscape of Enhancer RNAs in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus.

Authors:  Gangqiang Guo; Huijing Wang; Xinya Tong; Lele Ye; Xinyu Shi; Su Fang; Ya Hu; Fei Han; Chaosheng Chen; Ning Ding; Bofeng Su; Xiangyang Xue; Huidi Zhang
Journal:  J Inflamm Res       Date:  2022-02-04

6.  LINC01224/ZNF91 Promote Stem Cell-Like Properties and Drive Radioresistance in Non-Small Cell Lung Cancer.

Authors:  Wenfan Fu; Jian Zhao; Weimin Hu; Lu Dai; Zeyong Jiang; Shengpeng Zhong; Boyun Deng; Yun Huang; Wenjie Wu; Jun Yin
Journal:  Cancer Manag Res       Date:  2021-07-13       Impact factor: 3.989

7.  Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression.

Authors:  Ke Fang; Wei Huang; Yu-Meng Sun; Tian-Qi Chen; Zhan-Cheng Zeng; Qian-Qian Yang; Qi Pan; Cai Han; Lin-Yu Sun; Xue-Qun Luo; Wen-Tao Wang; Yue-Qin Chen
Journal:  Genome Biol       Date:  2020-11-03       Impact factor: 13.583

Review 8.  The emerging role of super enhancer-derived noncoding RNAs in human cancer.

Authors:  Yutong Wang; Hui Nie; Xiaoyun He; Zhiming Liao; Yangying Zhou; Jianhua Zhou; Chunlin Ou
Journal:  Theranostics       Date:  2020-09-02       Impact factor: 11.556

Review 9.  The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy.

Authors:  Guo Li; Yuan Tian; Wei-Guo Zhu
Journal:  Front Cell Dev Biol       Date:  2020-09-29

10.  DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinoma.

Authors:  Hao Wu; Jinrui Zhang; Yi Bai; Sai Zhang; Zhixin Zhang; Wen Tong; Pinsheng Han; Bing Fu; Yamin Zhang; Zhongyang Shen
Journal:  Aging (Albany NY)       Date:  2021-10-04       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.